Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Histopathology. 2019 Sep;75(3):394-404. doi: 10.1111/his.13892. Epub 2019 Jul 18.
Outcomes of colorectal cancer (CRC) treatment and survival have steadily improved during the past decades, accompanied by an increased risk of developing second primary tumours and metastatic tumours at unusual sites. Metastatic CRC can show mucosal colonisation, thereby mimicking a second primary tumour. This potential confusion could lead to incorrect diagnosis and consequently inadequate treatment of the patient. The aim of this study was to differentiate between metastatic CRC and a second primary (gallbladder cancer, GBC) using a combination of standard histopathology and molecular techniques.
Ten consecutive patients with both CRC and GBC were identified in our region using the Dutch National Pathology Archive (PALGA). Two patients served as negative controls. Histology of GBC was reviewed by nine pathologists. A combination of immunohistochemistry, microsatellite analysis, genomewide DNA copy number analysis and targeted somatic mutation analysis was used to aid in differential diagnosis. In two patients, CRC and GBC were clonally related, as confirmed by somatic mutation analysis. For one case, this was confirmed by genomewide DNA copy number analysis. However, in both cases, pathologists initially considered the GBC as a second primary tumour.
Metastatic CRC displaying mucosal colonisation is often misinterpreted as a second primary tumour. A combination of traditional histopathology and molecular techniques improves this interpretation, and lowers the risk of inadequate treatment.
在过去几十年中,结直肠癌(CRC)的治疗和生存结果稳步改善,但与此同时,发生第二原发肿瘤和转移至不常见部位的转移性肿瘤的风险也增加了。转移性 CRC 可能会出现黏膜定植,从而模拟第二原发肿瘤。这种潜在的混淆可能导致对患者的诊断错误,进而导致治疗不当。本研究的目的是使用标准组织病理学和分子技术相结合,区分转移性 CRC 和第二原发肿瘤(胆囊癌,GBC)。
我们使用荷兰全国病理档案库(PALGA)在我们的地区确定了 10 例同时患有 CRC 和 GBC 的连续患者,其中 2 例患者作为阴性对照。9 位病理学家对 GBC 的组织学进行了回顾。结合免疫组织化学、微卫星分析、全基因组 DNA 拷贝数分析和靶向体细胞突变分析,以辅助鉴别诊断。在 2 例患者中,CRC 和 GBC 具有克隆相关性,这通过体细胞突变分析得到了证实。对于 1 例病例,这通过全基因组 DNA 拷贝数分析得到了证实。然而,在这两种情况下,病理学家最初都将 GBC 视为第二原发肿瘤。
表现出黏膜定植的转移性 CRC 常被误诊为第二原发肿瘤。传统组织病理学和分子技术的结合可改善这种解释,并降低治疗不当的风险。